You are exactly correct and trust me everyone on this site and who owns the stock agrees with you 100% there are so many factors in play right now aspects of big pharmaceutical companies that actually don't want this to succeed is a big part of why it has not. Companies that are making hundreds of billions of dollars a year off of opioids certainly don't want this competing with them and they're revenues dropping. And they are not a hundred percent sure this product is going to be as effective and make as much money for them as their drugs do. So they're waiting and buying their time and if it proves out that the sales are exponential like we all believe they will be then yes there will be a gigantic buyout extremely fast on this company And not for $0.12 more like $1.00 Or more.
Market Data 
Markets 
AI
